ILLUMINA, INC.
ILMNNasdaq
$186.65
↓ -1.9%Jul 17 close · end-of-day
Price
1Y↑ +92.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$28.7B
Enterprise Value
$28.7B
P/E
33.9
P/S
6.5
P/B
10.7
EV/EBITDA
26.0
PEG
—
FCF Yield
3.4%
Dividend Yield
—
Revenue (TTM)
$4.4B
Net Income (TTM)
$853.0M
Free Cash Flow (TTM)
$974.0M
Gross Margin
66.2%
Operating Margin
19.4%
Net Margin
19.4%
ROE
31.9%
ROIC
26.2%
Debt / Equity
—
Net Cash
$66.0M
Return 1Y
+90.6%
Company profile
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.
- CEO
- Francis A. deSouza
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 11,500
- Headquarters
- California
- Website
- illumina.com
Management & directors
- Davies Scott MChief Legal Officer
- Leckman PatriciaSVP, Chief People Officer
- Ericksen Scott DVP, Chief Accounting Officer
- Wedel Christensen JakobSVP, Strategy/Corp Development
- Barnard StevenSVP, Chief Technology Officer
- Dhingra AnkurSVP, Chief Financial Officer
- Pegels Kevin CarlChief of Global Operations
- Thaysen JacobChief Executive Officer
- Cunningham EverettSVP, Chief Commercial Officer
Roles derived from SEC Form 4 filings.
Earnings
ILMN Q1 2026 Earnings
Period ends 2026-03-29
MetricActualYoY
Revenue$1.1B↑ +4.8%
Diluted EPS$0.87↑ +6.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $4.5B | $4.6B | $4.5B | $4.4B | $4.3B |
| Gross profit | $2.2B | $3.2B | $3.0B | $2.7B | $2.9B | $2.9B |
| Operating income | $580.0M | -$123.0M | -$4.2B | -$1.1B | -$833.0M | $807.0M |
| Net income | $656.0M | $762.0M | -$4.4B | -$1.2B | -$1.2B | $850.0M |
| Diluted EPS | $4.45 | $5.04 | -$28.00 | -$7.34 | -$7.69 | $5.45 |
| Operating cash flow | $1.1B | $545.0M | $392.0M | $478.0M | $837.0M | $1.1B |
| Free cash flow | $891.0M | $337.0M | $106.0M | $283.0M | $709.0M | $931.0M |
| Gross margin | 68.0% | 69.7% | 64.8% | 60.9% | 65.4% | 66.1% |
| Operating margin | 17.9% | -2.7% | -91.2% | -23.7% | -19.1% | 18.6% |
| Net margin | 20.3% | 16.8% | -96.1% | -25.8% | -28.0% | 19.6% |
| Line item | Q2 '24 | Q3 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.0B | $1.1B | $1.1B | $1.2B | $1.1B |
| Gross profit | $721.0M | $745.0M | $728.0M | $683.0M | $695.0M | $733.0M | $759.0M | $721.0M |
| Operating income | -$1.6B | $741.0M | $174.0M | $164.0M | $214.0M | $227.0M | $202.0M | $209.0M |
| Net income | -$2.0B | $705.0M | $186.0M | $131.0M | $235.0M | $150.0M | $334.0M | $134.0M |
| Diluted EPS | -$12.48 | $4.42 | $1.16 | $0.82 | $1.49 | $0.98 | $2.16 | $0.87 |
| Operating cash flow | $80.0M | $316.0M | $364.0M | $240.0M | $234.0M | $284.0M | $321.0M | $289.0M |
| Free cash flow | $49.0M | $284.0M | $335.0M | $208.0M | $204.0M | $253.0M | $266.0M | $251.0M |
| Gross margin | 64.8% | 69.0% | 65.9% | 65.6% | 65.6% | 67.6% | 65.5% | 66.1% |
| Operating margin | -147.2% | 68.6% | 15.8% | 15.8% | 20.2% | 20.9% | 17.4% | 19.2% |
| Net margin | -178.8% | 65.3% | 16.8% | 12.6% | 22.2% | 13.8% | 28.8% | 12.3% |
Company news
Jul 20, 2026
Jul 16, 2026
- 3d agoIllumina (ILMN) Faces German Recall Order Over Element Sequencing Patent Rulingfinance.yahoo.com
- 4d agoIllumina expands Billion Cell Atlas program with new AI drug developersfinance.yahoo.com
- 4d agoJuno Bio Opens First CLIA-Certified Sequencing Lab Dedicated Entirely to Women's Health, Backed by Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur Firstfinance.yahoo.com
Jul 14, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Ullem Scott B. | Award | 167 | $149.19 | $24,914.20 | filing |
| 2026-06-30 | Meister Keith A. | Award | 142 | $149.19 | $21,184.53 | filing |
| 2026-06-25 | Davies Scott M· Chief Legal Officer | Sale | 615 | $180.00 | $110,700.00 | filing |
| 2026-06-16 | Skovronsky Daniel | Award | 1,674 | $164.28 | $275,004.72 | filing |
| 2026-06-05 | Leckman Patricia· SVP, Chief People Officer | Sale | 374 | $162.78 | $60,879.72 | filing |
| 2026-06-05 | Leckman Patricia· SVP, Chief People Officer | Sale | 290 | $161.79 | $46,919.10 | filing |
| 2026-06-05 | Leckman Patricia· SVP, Chief People Officer | Sale | 78 | $163.36 | $12,742.08 | filing |
| 2026-06-05 | Leckman Patricia· SVP, Chief People Officer | Sale | 39 | $164.82 | $6,427.98 | filing |
| 2026-06-05 | Leckman Patricia· SVP, Chief People Officer | Sale | 2 | $167.88 | $335.76 | filing |
| 2026-06-02 | Leckman Patricia· SVP, Chief People Officer | Sale | 318 | $162.00 | $51,516.00 | filing |
| 2026-06-02 | Leckman Patricia· SVP, Chief People Officer | Sale | 290 | $163.02 | $47,275.80 | filing |
| 2026-06-02 | Leckman Patricia· SVP, Chief People Officer | Sale | 176 | $160.66 | $28,276.16 | filing |
| 2026-06-01 | Meister Keith A. | Sale | 87,653 | $164.34 | $14.4M | filing |
| 2026-06-01 | Meister Keith A. | Sale | 70,262 | $162.41 | $11.4M | filing |
| 2026-06-01 | Meister Keith A. | Sale | 61,613 | $163.56 | $10.1M | filing |
| 2026-06-01 | Meister Keith A. | Sale | 15,472 | $165.50 | $2.6M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 92,877 | $164.56 | $15.3M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 63,020 | $162.86 | $10.3M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 19,832 | $163.57 | $3.2M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 11,760 | $159.57 | $1.9M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 6,888 | $164.75 | $1.1M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 6,198 | $163.97 | $1.0M | filing |
| 2026-05-29 | Meister Keith A. | Sale | 5,256 | $161.64 | $849,579.84 | filing |
| 2026-05-29 | Meister Keith A. | Sale | 4,579 | $160.50 | $734,929.50 | filing |
| 2026-05-29 | Meister Keith A. | Sale | 2,225 | $162.44 | $361,429.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.